Pulse 2.0

Marrow Therapeutics Launches With $173 Million

Cover art for Marrow Therapeutics Launches With $173 Million

TL;DR: Marrow Therapeutics received $173 million in funding to develop genetic medicines for severe blood and bone marrow disorders. Marrow Therapeutics secures $173 million for bone marrow-targeted medicines to treat blood disorders. Marrow Therapeutics has launched with $173 million in combined Series A and Series B funding to develop genetic medicines for severe blood and bone marrow disorders.

Amit ChowdhryNov 17, 2026

From · · · 1m 40s

TL;DR: Marrow Therapeutics Launches With $173 Million

Marrow Therapeutics secures $173 million for bone marrow-targeted medicines to treat blood disorders.

Marrow Therapeutics received $173 million in funding to develop genetic medicines for severe blood and bone marrow disorders. Marrow Therapeutics secures $173 million for bone marrow-targeted medicines to treat blood disorders. Marrow Therapeutics has launched with $173 million in combined Series A and Series B funding to develop genetic medicines for severe blood and bone marrow disorders.

  • Funding Announcement
  • Funding Breakdown
  • Investors
  • Company Background

Read the story version — the same reporting as a swipeable deck of 9 cards.

Read the original on Pulse 2.0

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on marrow therapeutics and related topics.